Inovio Pharmaceuticals
INO
#8746
Rank
HK$1.26 B
Marketcap
HK$18.44
Share price
-8.85%
Change (1 day)
33.30%
Change (1 year)

EPS for Inovio Pharmaceuticals (INO)

EPS in 2025 (TTM): -HK$22.45

According to Inovio Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$22.41. In 2024 the company made an earnings per share (EPS) of -HK$30.73 an increase over its 2023 EPS that were of -HK$47.38.

EPS history for Inovio Pharmaceuticals from 1999 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$22.45-26.97%
2024-HK$30.73-35.14%
2023-HK$47.38-56.62%
2022-HK$109.24-19.54%
2021-HK$135.7735.9%
2020-HK$99.90-11.57%
2019-HK$112.9715.24%
2018-HK$98.04-2.78%
2017-HK$100.846.93%
2016-HK$94.30134.88%
2015-HK$40.15-29.51%
2014-HK$56.95-57.34%
2013-HK$133.51146.55%
2012-HK$54.1520.83%
2011-HK$44.82-29.41%
2010-HK$63.49-48.48%
2009-HK$123.2410%
2008-HK$112.0411.11%
2007-HK$100.84-41.3%
2006-HK$171.80-66.91%
2005-HK$519.12110.61%
2004-HK$246.49-61.63%
2003-HK$642.37186.67%
2002-HK$224.08
2001N/A-100%
2000-HK$179.26-63.64%
1999-HK$492.98

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
HK$13.38-159.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.22-462.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$9.73-56.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.27-355.56%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$59.08-363.67%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$27.98-224.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$50.73-326.39%๐Ÿ‡บ๐Ÿ‡ธ USA